WallStreetZenWallStreetZen

NASDAQ: CUE
Cue Biopharma Inc Stock Ownership - Who owns Cue Biopharma?

Insider buying vs selling

Have Cue Biopharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Anish SuriPRESIDENT AND CSO2023-08-254,000$2.76
$11.04kBuy
Daniel R. PasseriCHIEF EXECUTIVE OFFICER2023-08-143,000$2.86
$8.58kBuy

1 of 1

CUE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CUE insiders and whales buy or sell their stock.

CUE Shareholders

What type of owners hold Cue Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Slate Path Capital LP4.94%2,402,455$3.39MInstitution
Blackrock Inc4.81%2,338,765$3.30MInstitution
Vanguard Group Inc4.38%2,132,905$3.01MInstitution
Bleichroeder LP3.61%1,755,028$2.47MInstitution
Cameron Gray2.64%1,283,249$1.81MInsider
Aaron Gl Fletcher2.29%1,113,867$1.57MInsider
Geode Capital Management LLC1.67%813,285$1.15MInstitution
Christopher A. Marlett1.58%768,503$1.08MInsider
State Street Corp1.41%683,695$964.01kInstitution
Robertson Stephens Wealth Management LLC0.98%478,500$674.69kInstitution

1 of 3

CUE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CUE30.60%9.31%Net Buying
CLGN12.49%0.00%
DTIL53.55%46.45%Net Selling
CARM21.66%74.42%
CSBR1.90%98.10%Net Buying

Cue Biopharma Stock Ownership FAQ

Who owns Cue Biopharma?

Cue Biopharma (NASDAQ: CUE) is owned by 30.60% institutional shareholders, 9.31% Cue Biopharma insiders, and 60.09% retail investors. Cameron Gray is the largest individual Cue Biopharma shareholder, owning 1.28M shares representing 2.64% of the company. Cameron Gray's Cue Biopharma shares are currently valued at $1.75M.

If you're new to stock investing, here's how to buy Cue Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.